125 Antimicrobial Stewardship: Moving Beyond the Guideline

Sunday, March 21, 2010: 4:00 PM-6:00 PM
Centennial I-II (Hyatt Regency Atlanta)
CME Credits: 2
Type: Oral
Summary: In the absence of the development of new antimicrobial agents to treat infections caused by emerging MDROs, antimicrobial stewardship is a vital weapon in the war against resistance. The IDSA/SHEA Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship was published in January 2007. While antimicrobial stewardship will soon be required in the EU, adoption and dissemination of the guidelines has been slow in the US. This session will explain the new EU regulations and explore the limitations of the science of antimicrobial stewardship, and then focus on moving the field forward during the next decade.
Learning Objectives:
Co-Organized by:
Society of Infectious Diseases Pharmacists (SIDP)
Herman Goossens, PhD and J. Todd Weber, MD
4:00 PM
Antimicrobial Stewardship Regulations in the EU
Dominique L. Monnet, PharmD, PhD, European Centre for Disease Prevention and Control
4:40 PM
Challenges of Proving the Impact of Antimicrobial Stewardship
Ebbing Lautenbach, MD, MPH, MSCE, University of Pennsylvania School of Medicine
5:20 PM
Moving the Science of Antimicrobial Stewardship Forward in the Next Decade
Sara Cosgrove, MD, Johns Hopkins School of Medicine